The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PDL BioPharma Inc

Nasdaq: PDLI
Last

(U.S.) $3.77

Today's change+0.01 +0.27%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

PDL BioPharma Inc

Nasdaq: PDLI
Last

(U.S.) $3.77

Today's change+0.01 +0.27%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

PDL BioPharma Inc up (U.S.)$0.01

PDL BioPharma Inc closed up Friday by (U.S.)$0.01 or 0.27% to (U.S.)$3.77. Shares have lost 1.31% over the last five days, but have gained 6.50% over the last year to date. This security has underperformed the S&P 500 by 42.51% during the last year.

Key company metrics

  • Open(U.S.) $3.74
  • Previous close(U.S.) $3.76
  • High(U.S.) $3.82
  • Low(U.S.) $3.70
  • Bid / Ask(U.S.) $3.65 / (U.S.) $3.90
  • YTD % change+6.50%
  • Volume2,186,306
  • Average volume (10-day)1,528,627
  • Average volume (1-month)2,033,328
  • Average volume (3-month)2,311,519
  • 52-week range(U.S.) $2.58 to (U.S.) $6.93
  • Beta0.69
  • Trailing P/E1.88×
  • P/E 1 year forward5.68×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.20
  • Dividend yield5.31%
  • Trailing EPS(U.S.) $2.01
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue178125138150
Total other revenue--------
Total revenue178125138150
Gross profit--------
Total cost of revenue--------
Total operating expense10878
Selling / general / administrative13878
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-2000
Other operating expenses, total--------
Operating income168116131142
Interest income (expense), net non-operating-5-6-7-9
Gain (loss) on sale of assets--------
Other--------
Income before tax163110124134
Income after tax101697884
Income tax, total62414549
Net income101697884
Total adjustments to net income--------
Net income before extra. items101697884
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items101697884
Inc. avail. to common incl. extra. items101697884
Diluted net income101697885
Dilution adjustment------1
Diluted weighted average shares165164165170
Diluted EPS excluding extraordinary itemsvalue per share0.610.420.470.50
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share0.600.420.470.50